ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 145 filers reported holding ITEOS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $605,531 | -2.7% | 45,735 | 0.0% | 0.02% | 0.0% |
| Q1 2023 | $622,453 | +42.8% | 45,735 | +115.9% | 0.02% | +41.2% |
| Q2 2022 | $436,000 | -68.0% | 21,181 | -50.0% | 0.02% | -64.6% |
| Q1 2022 | $1,363,000 | -30.9% | 42,362 | 0.0% | 0.05% | -23.8% |
| Q4 2021 | $1,972,000 | +72.4% | 42,362 | 0.0% | 0.06% | +70.3% |
| Q3 2021 | $1,144,000 | – | 42,362 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 2,738,785 | $29,989,696 | 16.06% |
| MPM BioImpact LLC | 1,745,943 | $19,118,076 | 5.10% |
| Saturn V Capital Management LP | 994,756 | $10,892,578 | 4.56% |
| Boxer Capital, LLC | 1,804,058 | $19,754,435 | 1.05% |
| RA Capital Management | 4,417,259 | $48,368,986 | 0.95% |
| 683 Capital Management, LLC | 810,000 | $8,869,500 | 0.69% |
| Ikarian Capital, LLC | 346,471 | $3,793,857 | 0.46% |
| Ikarian Capital, LLC | 3,056 | $3,346,320 | 0.40% |
| BVF INC/IL | 1,259,476 | $13,791,262 | 0.37% |
| DAFNA Capital Management LLC | 98,560 | $1,079,232 | 0.34% |